Hoon Sung Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hoon Sung Choi has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- Young Joo Park
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
8 shared publications - Jin Taek Kim
Department of Internal Medicine, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Korea
6 shared publications - Kyong Yeun Jung
Department of Internal Medicine, Nowon Eulji Medical Center, Eulji University, Seoul, Republic of Korea
5 shared publications - Sun Wook Cho
Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
5 shared publications Do Joon Park
Department of Internal Medicine Seoul National University Hospital Seoul National University College of Medicine Seoul Korea
4 shared publications- Hong Kyu Lee
Department of Internal Medicine, Seoul National University College of Medicine, Seoul 03087, Republic of Korea
4 shared publications
Latest Publications
- Open Access
- 30 December 2025
- Published by The Korean Society for Laser Medicine and Surgery in Medical Lasers
- Vol. 14 (4) , 244-252
The impact of chronic diseases on non-invasive blood glucose measurement using near-infrared spectroscopy in Republic of Korea: retrospective clinical study
Hoonsung Choi, Meihua Jin, Won Sang Yoo. Med Lasers 2025;14:244-52. https://doi.org/10.25289/ML.25.024
- 30 December 2025
- Published by The Korean Society for Laser Medicine and Surgery in Medical Lasers
- Vol. 14 (4) , 244-252
Open AccessThe impact of chronic diseases on non-invasive blood glucose measurement using near-infrared spectroscopy in Republic of Korea: retrospective clinical study
Hoonsung Choi, Meihua Jin, Won Sang Yoo. Med Lasers 2025;14:244-52. https://doi.org/10.25289/ML.25.024
- Open Access
- 30 November 2025
- Published by Korean Thyroid Association in International Journal of Thyroidology
- Vol. 18 (2) , 171-179
The Changes of Weight, Body Composition and Metabolic Parameters According to Treatment Modality in Patients with Thyroid Cancer
Kyong Yeun Jung, Hoon Sung Choi, Sun Wook Cho, Hyun Kyung Chung, Hee Jin Kim and Young Joo Park. Int J Thyroidol 2025;18:171-9. https://doi.org/10.11106/ijt.2025.18.2.171
- 30 November 2025
- Published by Korean Thyroid Association in International Journal of Thyroidology
- Vol. 18 (2) , 171-179
Open AccessThe Changes of Weight, Body Composition and Metabolic Parameters According to Treatment Modality in Patients with Thyroid Cancer
Kyong Yeun Jung, Hoon Sung Choi, Sun Wook Cho, Hyun Kyung Chung, Hee Jin Kim and Young Joo Park. Int J Thyroidol 2025;18:171-9. https://doi.org/10.11106/ijt.2025.18.2.171
- Open Access
- 30 November 2025
- Published by Korean Thyroid Association in International Journal of Thyroidology
- Vol. 18 (2) , 140-148
Levothyroxine Dosing after Total Thyroidectomy and Radioactive Iodine Treatment: Development and Validation of a Unified Predictive Formula
Soo Myoung Shin, Kyong Yeun Jung, Hoonsung Choi, Jae Hoon Moon, Sun Wook Cho, Ka Hee Yi and Young Joo Park. Int J Thyroidol 2025;18:140-8. https://doi.org/10.11106/ijt.2025.18.2.140
- 30 November 2025
- Published by Korean Thyroid Association in International Journal of Thyroidology
- Vol. 18 (2) , 140-148
Open AccessLevothyroxine Dosing after Total Thyroidectomy and Radioactive Iodine Treatment: Development and Validation of a Unified Predictive Formula
Soo Myoung Shin, Kyong Yeun Jung, Hoonsung Choi, Jae Hoon Moon, Sun Wook Cho, Ka Hee Yi and Young Joo Park. Int J Thyroidol 2025;18:140-8. https://doi.org/10.11106/ijt.2025.18.2.140
- Open Access
- 31 August 2025
- Published by Korean Endocrine Society in Endocrinology and Metabolism
- Vol. 40 (4) , 653-654
Study Protocol of Expanded Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro-EXP) (Endocrinol Metab 2025;40:236-46, Jae Hoon Moon et al.)
Detailed risk stratification patients with low-risk thyroid cancer. By refining risk criteria, the approach can reduce unnecessary thyroid surgeries, thereby preventing surgery-associated complications and preserving patients' quality of life. Additionally, it may contribute to a more efficient allocation of healthcare resources across the medical system.
- 31 August 2025
- Published by Korean Endocrine Society in Endocrinology and Metabolism
- Vol. 40 (4) , 653-654
Open AccessStudy Protocol of Expanded Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro-EXP) (Endocrinol Metab 2025;40:236-46, Jae Hoon Moon et al.)
Detailed risk stratification patients with low-risk thyroid cancer. By refining risk criteria, the approach can reduce unnecessary thyroid surgeries, thereby preventing surgery-associated complications and preserving patients' quality of life. Additionally, it may contribute to a more efficient allocation of healthcare resources across the medical system.
- Open Access
- 4 April 2025
- Published by AVES YAYINCILIK A.Ş. in Endocrinology Research and Practice
- Vol. 29 (2) , 94-100
Higher Urine Specific Gravity Associated with Higher Fasting Blood Glucose Levels and Insulin Resistance: A 10-year Korean Cohort Study
Objective: A consensus on whether the body’s hydration status is associated with the incidence of diabetes and insulin resistance has not yet been reached. The association between urine specific gravity (USG) and metabolic derangement or diabetes risk over time was aimed to be investigated. Methods: Data from 2498 middle-aged men and women who initially showed normoglycemia at baseline over a 10-year follow-up period from a population-based Korean cohort study were used. Survival and panel analyses were performed to evaluate the effect of USG on serum glucose levels, insulin resistance, and the risk of diabetes, Results: During 24 578 person-years of follow-up, the incidence rate of diabetes was 5.2 (95% CI: 4.4-6.2) per 1000 person-years. In survival analyses, USG did not show a significant increase in the incidence of diabetes. Panel regression analysis showed that individuals with higher USG (≥1.03) exhibited significantly elevated fasting blood glucose (FBG) levels and a homeostatic model assess ment for insulin resistance (HOMA-IR) compared with those with a lower USG (<1.02). A high USG did not show a significant risk of diabetes but did show an increasing effect on FBG levels and HOMA-IR over a 10-year follow-up period. Conclusion: Elevated USG was associated with increased FBG levels and insulin resistance in the lon gitudinal panel analysis over 10 years. More research is needed to investigate the association of water intake with insulin resistance and diabetes. Cite this article as: Choi H, Moon TJ, Kwon JY, et al. Higher urine specific gravity associated with higher fasting blood glucose levels and insulin resistance: A 10-year Korean cohort study. Endocrinol Res Pract. 2025;29(2):94-100.
- 4 April 2025
- Published by AVES YAYINCILIK A.Ş. in Endocrinology Research and Practice
- Vol. 29 (2) , 94-100
Open AccessHigher Urine Specific Gravity Associated with Higher Fasting Blood Glucose Levels and Insulin Resistance: A 10-year Korean Cohort Study
Objective: A consensus on whether the body’s hydration status is associated with the incidence of diabetes and insulin resistance has not yet been reached. The association between urine specific gravity (USG) and metabolic derangement or diabetes risk over time was aimed to be investigated. Methods: Data from 2498 middle-aged men and women who initially showed normoglycemia at baseline over a 10-year follow-up period from a population-based Korean cohort study were used. Survival and panel analyses were performed to evaluate the effect of USG on serum glucose levels, insulin resistance, and the risk of diabetes, Results: During 24 578 person-years of follow-up, the incidence rate of diabetes was 5.2 (95% CI: 4.4-6.2) per 1000 person-years. In survival analyses, USG did not show a significant increase in the incidence of diabetes. Panel regression analysis showed that individuals with higher USG (≥1.03) exhibited significantly elevated fasting blood glucose (FBG) levels and a homeostatic model assess ment for insulin resistance (HOMA-IR) compared with those with a lower USG (<1.02). A high USG did not show a significant risk of diabetes but did show an increasing effect on FBG levels and HOMA-IR over a 10-year follow-up period. Conclusion: Elevated USG was associated with increased FBG levels and insulin resistance in the lon gitudinal panel analysis over 10 years. More research is needed to investigate the association of water intake with insulin resistance and diabetes. Cite this article as: Choi H, Moon TJ, Kwon JY, et al. Higher urine specific gravity associated with higher fasting blood glucose levels and insulin resistance: A 10-year Korean cohort study. Endocrinol Res Pract. 2025;29(2):94-100.
- Open Access
- 30 November 2024
- Published by Korean Thyroid Association in International Journal of Thyroidology
- Vol. 17 (2) , 266-271
Extrathyroidal Extension in Papillary Thyroid Cancer Could be Predicted Through Preoperative Sonography
Go Eun Yang, Sung Whi Cho, Yoon Jong Ryu, Kyoung Yul Lee, Hwan Soo Kim, Taek Geun Ohk and Hoonsung Choi. Int J Thyroidol 2024;17:266-71. https://doi.org/10.11106/ijt.2024.17.2.266
- 30 November 2024
- Published by Korean Thyroid Association in International Journal of Thyroidology
- Vol. 17 (2) , 266-271
Open AccessExtrathyroidal Extension in Papillary Thyroid Cancer Could be Predicted Through Preoperative Sonography
Go Eun Yang, Sung Whi Cho, Yoon Jong Ryu, Kyoung Yul Lee, Hwan Soo Kim, Taek Geun Ohk and Hoonsung Choi. Int J Thyroidol 2024;17:266-71. https://doi.org/10.11106/ijt.2024.17.2.266
- Open Access
Relationships among Dioxin-like Mitochondria Inhibitor Substances (MIS)-Mediated Mitochondria Dysfunction, Obesity, and Lung Function in a Korean Cohort
Mitochondrial dysfunction is closely linked to obesity and diabetes, with declining lung function in aging increasing diabetes risk, potentially due to elevated serum levels of dioxin-like mitochondria inhibitor substances (MIS) from prolonged exposure to environmental pollutants. However, the mechanisms connecting MIS, mitochondria, lung function, and metabolic disorder remain unclear. In this study, we analyzed data from 1371 adults aged 40–69 years in the 2008 Korean Genome Epidemiologic Study (KoGES) Ansung cohort. We indirectly estimated dioxin-like MIS levels by measuring intracellular ATP (MISATP) and reactive oxygen species (MISROS) in cultured cells treated with the serum of participants. Using correlation analysis and structural equation modeling (SEM), we explored the relationships among MIS, mitochondrial function, body mass index (BMI), and lung function (FEV1 and FVC). Our findings revealed that MISATP was associated with BMI in females and with FVC in males, while MISROS correlated with both BMI and FVC in males, not in females. Significant associations between BMI and FVC were found in the highest MIS subgroup in both sexes. SEM analyses demonstrated that MIS negatively influenced mitochondrial function, which in turn affected BMI and lung function. Age-related declines in lung function were also linked to mitochondrial dysfunction. This study underscores the potential of MIS assays as alternatives for assessing mitochondrial function and highlights the importance of mitochondrial health in metabolic disorders and lung function.
Open AccessRelationships among Dioxin-like Mitochondria Inhibitor Substances (MIS)-Mediated Mitochondria Dysfunction, Obesity, and Lung Function in a Korean Cohort
Mitochondrial dysfunction is closely linked to obesity and diabetes, with declining lung function in aging increasing diabetes risk, potentially due to elevated serum levels of dioxin-like mitochondria inhibitor substances (MIS) from prolonged exposure to environmental pollutants. However, the mechanisms connecting MIS, mitochondria, lung function, and metabolic disorder remain unclear. In this study, we analyzed data from 1371 adults aged 40–69 years in the 2008 Korean Genome Epidemiologic Study (KoGES) Ansung cohort. We indirectly estimated dioxin-like MIS levels by measuring intracellular ATP (MISATP) and reactive oxygen species (MISROS) in cultured cells treated with the serum of participants. Using correlation analysis and structural equation modeling (SEM), we explored the relationships among MIS, mitochondrial function, body mass index (BMI), and lung function (FEV1 and FVC). Our findings revealed that MISATP was associated with BMI in females and with FVC in males, while MISROS correlated with both BMI and FVC in males, not in females. Significant associations between BMI and FVC were found in the highest MIS subgroup in both sexes. SEM analyses demonstrated that MIS negatively influenced mitochondrial function, which in turn affected BMI and lung function. Age-related declines in lung function were also linked to mitochondrial dysfunction. This study underscores the potential of MIS assays as alternatives for assessing mitochondrial function and highlights the importance of mitochondrial health in metabolic disorders and lung function.
Shortened telomere length in peripheral blood leukocytes is associated with cumulative radioactive iodine doses in patients with differentiated thyroid carcinoma
Background: Telomere length is associated with cancer risk and cancer aggressiveness. Radioactive iodine (RAI) therapy for thyroid cancer has raised concerns for second primary malignancy (SPM) in patients with high cumulative doses. The association between RAI dose and peripheral blood leukocyte telomere length was examined.Methods: A total of 425 patients were included who underwent total thyroidectomy and were followed up for at least 1 year with or without RAI treatment. The relative telomere length (RTL) of the patients was assessed via a quantitative polymerase chain reaction amplification method. RAI doses were divided into five groups on the basis of cumulative dose, and a comparison was made among these groups.Results: The number of patients with RAI treatment was 287 (67.5%), and the cumulative RAI dose was 3.33 GBq (range, 1.11–131.35 GBq). The mean RTL was significantly shorter in the highest RAI group (>22.2 GBq) compared to both the no‐RAI and lower dose groups. The association between RAI dose and RTL was positive in the lower RAI group (1.1–3.7 GBq) and negative in the highest RAI group in both univariate and multivariate analyses. We observed 59 (13.9%) SPMs and 20 (4.7%) mortalities, and RTL did not show a significant risk effect for all‐cause, thyroid cancer–specific, or SPM‐specific mortality.Conclusions: In patients with thyroid cancer who underwent total thyroidectomy, peripheral blood leukocyte telomere length exhibited a significant association with cumulative RAI dose higher than 22.2 GBq. These results suggest the possibility of telomere length shortening in patients who undergo high‐dose RAI treatment.
Shortened telomere length in peripheral blood leukocytes is associated with cumulative radioactive iodine doses in patients with differentiated thyroid carcinoma
Background: Telomere length is associated with cancer risk and cancer aggressiveness. Radioactive iodine (RAI) therapy for thyroid cancer has raised concerns for second primary malignancy (SPM) in patients with high cumulative doses. The association between RAI dose and peripheral blood leukocyte telomere length was examined.Methods: A total of 425 patients were included who underwent total thyroidectomy and were followed up for at least 1 year with or without RAI treatment. The relative telomere length (RTL) of the patients was assessed via a quantitative polymerase chain reaction amplification method. RAI doses were divided into five groups on the basis of cumulative dose, and a comparison was made among these groups.Results: The number of patients with RAI treatment was 287 (67.5%), and the cumulative RAI dose was 3.33 GBq (range, 1.11–131.35 GBq). The mean RTL was significantly shorter in the highest RAI group (>22.2 GBq) compared to both the no‐RAI and lower dose groups. The association between RAI dose and RTL was positive in the lower RAI group (1.1–3.7 GBq) and negative in the highest RAI group in both univariate and multivariate analyses. We observed 59 (13.9%) SPMs and 20 (4.7%) mortalities, and RTL did not show a significant risk effect for all‐cause, thyroid cancer–specific, or SPM‐specific mortality.Conclusions: In patients with thyroid cancer who underwent total thyroidectomy, peripheral blood leukocyte telomere length exhibited a significant association with cumulative RAI dose higher than 22.2 GBq. These results suggest the possibility of telomere length shortening in patients who undergo high‐dose RAI treatment.
- Open Access
- 1 January 2024
- Published by XMLink in Nutrition Research and Practice
- Vol. 18 (5) , 711-720
Association between food consumption and serum aryl hydrocarbon receptor ligand activity among middle-aged Korean adults
Ha K, et al. Nutr Res Pract. 2024 Oct;18(5):711-720. https://doi.org/10.4162/nrp.2024.18.5.711
- 1 January 2024
- Published by XMLink in Nutrition Research and Practice
- Vol. 18 (5) , 711-720
Open AccessAssociation between food consumption and serum aryl hydrocarbon receptor ligand activity among middle-aged Korean adults
Ha K, et al. Nutr Res Pract. 2024 Oct;18(5):711-720. https://doi.org/10.4162/nrp.2024.18.5.711
- Open Access
- 31 December 2023
- Published by Korean Society of Pediatric Endocrinology in Annals of Pediatric Endocrinology & Metabolism
- Vol. 28 (4) , 296-301
Effects of once-weekly dulaglutide on juvenile type 2 diabetes mellitus and obesity in Korea: a pilot study
Purpose: We sought to investigate the effects and side effects of once-weekly dulaglutide treatment for type 2 diabetes mellitus (T2DM) in patients <18 years of age in Korea.Methods: : From the Eulji University Hospital database, we identified all patients <18 years of age diagnosed with T2DM and treated with dulaglutide from January 1, 2017, to July 31, 2022.Results: We identified 5 patients <18 years of age treated with dulaglutide for T2DM management. Their mean (standard deviation [SD]) age was 16.6 (0.5) years. Four (80%) patients were female. The mean (SD) body mass index was 29.4 (5.1) kg/m2, and the mean (SD) age at diagnosis was 15.2 (1.6) years. Four patients had been treated previously with metformin alone or in combination with insulin. Four patients were treated with 1.5 mg of dulaglutide and one was treated with 0.75 mg of dulaglutide. The mean (SD) hemoglobin A1c concentrations at baseline, 3 months after treatment, and 1 year after treatment, respectively, were 10.0% (2.2%), 6.5% (1.5%), and 6.7% (1.4%), with significant differences. In addition, at baseline, 3 months after treatment, and 1 year after treatment, the mean (SD) body weight values were 79.7 (13.3) kg, 80.2 (14.0) kg, and 81.1 (15.3) kg, with no significant difference.Conclusion: Use of once-weekly dulaglutide for juvenile T2DM ensures very good glycemic control, with few side effects and good adherence, indicating its potential as a promising therapeutic agent in this age group. Nationwide studies are warranted to confirm our results.
- 31 December 2023
- Published by Korean Society of Pediatric Endocrinology in Annals of Pediatric Endocrinology & Metabolism
- Vol. 28 (4) , 296-301
Open AccessEffects of once-weekly dulaglutide on juvenile type 2 diabetes mellitus and obesity in Korea: a pilot study
Purpose: We sought to investigate the effects and side effects of once-weekly dulaglutide treatment for type 2 diabetes mellitus (T2DM) in patients <18 years of age in Korea.Methods: : From the Eulji University Hospital database, we identified all patients <18 years of age diagnosed with T2DM and treated with dulaglutide from January 1, 2017, to July 31, 2022.Results: We identified 5 patients <18 years of age treated with dulaglutide for T2DM management. Their mean (standard deviation [SD]) age was 16.6 (0.5) years. Four (80%) patients were female. The mean (SD) body mass index was 29.4 (5.1) kg/m2, and the mean (SD) age at diagnosis was 15.2 (1.6) years. Four patients had been treated previously with metformin alone or in combination with insulin. Four patients were treated with 1.5 mg of dulaglutide and one was treated with 0.75 mg of dulaglutide. The mean (SD) hemoglobin A1c concentrations at baseline, 3 months after treatment, and 1 year after treatment, respectively, were 10.0% (2.2%), 6.5% (1.5%), and 6.7% (1.4%), with significant differences. In addition, at baseline, 3 months after treatment, and 1 year after treatment, the mean (SD) body weight values were 79.7 (13.3) kg, 80.2 (14.0) kg, and 81.1 (15.3) kg, with no significant difference.Conclusion: Use of once-weekly dulaglutide for juvenile T2DM ensures very good glycemic control, with few side effects and good adherence, indicating its potential as a promising therapeutic agent in this age group. Nationwide studies are warranted to confirm our results.